HK$7.85
4.38% yesterday
Hong Kong, Oct 24, 10:00 am CET
ISIN
HK1093012172
Symbol
1093
Index

CSPC Pharmaceutical Group Limited Stock price

HK$7.89
-1.56 16.51% 1M
+1.75 28.50% 6M
+3.11 65.06% YTD
+1.74 28.29% 1Y
-0.37 4.48% 3Y
-0.65 7.61% 5Y
+4.13 109.82% 10Y
+7.10 896.59% 20Y
Hong Kong, Closing price Fri, Oct 24 2025
-0.32 3.90%
ISIN
HK1093012172
Symbol
1093
Index
Industry

Key metrics

Basic
Market capitalization
HK$94.4b
Enterprise Value
HK$84.4b
Net debt
positive
Cash
HK$10.6b
Shares outstanding
11.5b
Valuation (TTM | estimate)
P/E
21.3 | 15.4
P/S
3.3 | 2.9
EV/Sales
3.0 | 2.6
EV/FCF
26.3
P/B
2.6
Dividends
DPS
HK$0.24
Yield 1Y | 5Y
2.9% | 2.9%
Growth 1Y | 5Y
-20.0% | 8.1%
Payout 1Y | 3Y
60.0% | 52.7%
Increased
0 Years
Financials (TTM | estimate)
Revenue
HK$28.4b | HK$32.4b
EBITDA
- | HK$9.2b
EBIT
HK$5.4b | HK$7.7b
Net Income
HK$4.2b | HK$5.9b
Free Cash Flow
HK$3.2b
Growth (TTM | estimate)
Revenue
-17.9% | 2.5%
EBITDA
- | 21.3%
EBIT
-36.1% | 25.9%
Net Income
-34.9% | 25.1%
Free Cash Flow
10.1%
Margin (TTM | estimate)
Gross
66.8%
EBITDA
- | 28.4%
EBIT
19.1%
Net
14.8% | 18.2%
Free Cash Flow
11.3%
Financial Health
Equity Ratio
72.7%
Return on Equity
13.4%
ROCE
13.8%
ROIC
14.7%
Debt/Equity
0.0
More
EPS
HK$0.4
FCF per Share
HK$0.3
Short interest
-
Employees
21k
Rev per Employee
HK$1.5m
Show more

Is CSPC Pharmaceutical Group Limited a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,040 stocks worldwide.

CSPC Pharmaceutical Group Limited Stock Analysis

Unlock Scores for Free

Analyst Opinions

32 Analysts have issued a CSPC Pharmaceutical Group Limited forecast:

22x Buy
69%
8x Hold
25%
2x Sell
6%

Analyst Opinions

32 Analysts have issued a CSPC Pharmaceutical Group Limited forecast:

Buy
69%
Hold
25%
Sell
6%

Financial data from CSPC Pharmaceutical Group Limited

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
28,365 28,365
18% 18%
100%
- Direct Costs 9,431 9,431
5% 5%
33%
18,934 18,934
23% 23%
67%
- Selling and Administrative Expenses 8,499 8,499
25% 25%
30%
- Research and Development Expense 5,817 5,817
5% 5%
21%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 5,411 5,411
36% 36%
19%
Net Profit 4,206 4,206
35% 35%
15%

In millions HKD.

Don't miss a Thing! We will send you all news about CSPC Pharmaceutical Group Limited directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the following business segments: Finished Drugs, Antibiotics, Vitamin C, Caffeine and Others. The company was founded on August 21, 1997 and is headquartered in Hong Kong.

Head office Hong Kong
CEO Cui Zhang
Employees 21,400
Founded 1997
Website www.cspc.com.hk

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today